# SPIRONOLACTONE

NDC: 59651-428
Generic name: SPIRONOLACTONE
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20191213

FDA application: ANDA202187

## Active ingredients

- SPIRONOLACTONE: 100 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"59651-428"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=59651-428
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=768563dc-a619-44dc-b97f-1a7e71fd56a0
